Semih Gultekin Co-Founded Kanurra Secures $6.5M in Funding

Kanurra, a NYC-based pharmacy benefit manager, has secured $6.5 million in a funding round.

The round saw backers including Necessary Ventures, Asylum Ventures, Daybreak Ventures, Virtue VC, Ford Street Ventures, and Browder Capital.

The company plans to use the funding to expand its operations, business reach, and product development.

What is Kanurra?

Kanurra is a pharmacy benefit manager focused on providing employers with a flat-fee and pass-through pricing model for prescription drugs.

Instead of making money through drug price spreads, hidden fees, or retained rebates, Kanurra charges employers a flat administrative fee and passes drug costs through without adding a markup.

Read More:Millennial Shift Technologies Partners with PebbleRisk

The company focuses on self-funded and level-funded employers, particularly small and mid-sized businesses.

How Much Funding Has Kanurra Secured?

Kanurra has secured $6.5 million in its latest funding round.

The source does not provide details of any previous funding rounds or the company's total funding to date.

Who Invested in Kanurra’s Funding Round?

The funding round included:

• Necessary Ventures
• Asylum Ventures
• Daybreak Ventures
• Virtue VC
• Ford Street Ventures
• Browder Capital

Why the Funding Matters

Kanurra plans to use the funding to expand its operations, reach more businesses, and continue developing its platform.

Its pricing model is designed to give employers a clearer view of prescription drug costs by separating the company's administrative fee from the cost of the medication.

Who founded Kanurra?

Kanurra was founded in 2026 by Semih Gultekin.

The company is headquartered in New York City.

Kanurra's founder, Semih Gultekin, says he seeks to “eliminate confusion and increase the accessibility of prescription medications.” Kanurra will partner with self-funded and level-funded employers, with a specialty in small and medium-sized businesses. As opposed to legacy PBMs, Kanurra prides itself on its auditability.

Market and Business Growth

Kanurra focuses on self-funded and level-funded employers, with an emphasis on small and mid-sized businesses.

Under its pass-through model, plan sponsors pay the same amount that pharmacies are reimbursed for a drug, without a markup, spread, or retained rebate.

What Happens Next?

Kanurra plans to expand its business reach and operations while continuing to develop its pharmacy benefit management platform.

The company will focus on serving more self-funded and level-funded employers through its flat-fee, pass-through pricing model.

Read More:NYC-Based EliseAI Raises $350 Million in Series F Funding